Edition:
United States

Medpace Holdings Inc (MEDP.OQ)

MEDP.OQ on NASDAQ Stock Exchange Global Select Market

36.38USD
14 Dec 2017
Change (% chg)

$0.38 (+1.06%)
Prev Close
$36.00
Open
$35.96
Day's High
$36.84
Day's Low
$35.65
Volume
98,039
Avg. Vol
61,956
52-wk High
$39.61
52-wk Low
$21.76

Chart for

About

Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development... (more)

Overall

Beta: --
Market Cap(Mil.): $1,361.69
Shares Outstanding(Mil.): 37.43
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 196.13 16.04
EPS (TTM): -- -- --
ROI: -- -11.69 35.70
ROE: -- -36.44 15.40

BRIEF-Medpace Holdings Prices Secondary Offering Of 4 Mln Shares At $31.50 Per Share​

* MEDPACE HOLDINGS, INC. ANNOUNCES PRICING OF SECONDARY OFFERING OF COMMON STOCK BY SELLING SHAREHOLDER

Nov 30 2017

BRIEF-Medpace Holdings files for mixed shelf of up to $75 million ‍​

* Medpace Holdings Inc files for mixed shelf of up to $75 million - SEC filing ‍​

Sep 01 2017

BRIEF-Medpace Holdings announces stock repurchase agreement with Cinven

* Medpace Holdings announces stock repurchase agreement with Cinven

Aug 16 2017

BRIEF-Medpace Holdings Q2 earnings per share $0.23

* Q2 earnings per share view $0.30 -- Thomson Reuters I/B/E/S

Jul 31 2017

BRIEF-Medpace Holdings says Medpace Limited Partnership entered into credit agreement

* Medpace Holdings Inc - ‍on june 16, 2017, medpace limited partnership ( borrower) entered into a credit agreement - SEC filing

Jun 21 2017

Earnings vs. Estimates